LENEXA, Kan., Oct. 27, 2005 (PRIMEZONE) -- Mediware Information Systems, Inc. (Nasdaq:MEDW) announced that Tarzana Treatment Centers has begun implementing Mediware's WORx(r), MediMAR(tm) and MediCOE(tm) solutions to increase operational efficiencies and to satisfy medication delivery standards for its patient safety initiatives.
Tarzana Treatment Centers is a non-profit organization providing a range of services for adult and teen/youth including medication detoxification, residential rehabilitation treatment, substance abuse, outpatient services and mental health treatment.
"We looked closely at several systems before choosing Mediware. Its Medication Management suite will allow us to accomplish a number of important goals. First, it will allow us to provide the safest possible medication environment for our clients. Second, it will help our staff by reducing the amount of manual documentation they need to accomplish and, finally, it will help us manage our business by giving us easy access to information about our drug costs and drug utilization that we have never had before," said Albert Senella, Chief Operating Officer, Tarzana Treatment Centers.
Through the use of Mediware's WORx integrated suite of solutions, Tarzana will achieve many medication delivery objectives. "Our implementation of Mediware's closed-loop medication solution is just the most recent example of the ongoing commitment we have to provide the best possible treatment to our clients. It also continues a 30-year legacy of leadership that Tarzana Treatment Centers has shown to our industry," said Scott Taylor, CEO and Chairman of the Board of Tarzana Treatment Centers.
The Medication Management integrated suite of solutions will offer Tarzana a common longitudinal view of a patient's current and past medication profile to physicians, pharmacists and nurses as well as immediate access to a variety of commercial drug reference databases and 5-rights verification through bar coding.
"We are pleased that Tarzana has decided to allow us to leverage our 20-plus years of experience delivering medication solutions to the benefit of its clients and staff. Our unique, medication-focused approach to improving patient safety is allowing us to deliver to Tarzana a complete and truly integrated closed-loop medication solution quickly and cost-efficiently," said Neil Moore, Executive Vice President of Sales and Marketing, Mediware.
About Tarzana Treatment Centers
Founded in 1972, Tarzana Treatment Centers, Inc. is a full-service behavioral healthcare organization that provides high-quality, cost-effective substance abuse and mental health treatment to adults and youths. It is a non-profit, community-based organization that operates a psychiatric hospital, residential and outpatient treatment centers and family medical clinics. All facilities are licensed and certified by the State of California and the County of Los Angeles and are accredited by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO).
About Mediware
Mediware Information Systems, Inc., founded in 1980, is a leading provider of best-of-breed clinical information systems to the health care industry in three areas: pharmacies, blood banks and surgical suites. More than 1,100 systems are installed in hospitals and health care institutions in the United States and around the world.
Its products include HCLL(tm) Transfusion, HCLL(tm) Donor, LifeTrak(r), IIE(tm) (Instrument Interface Engine), Hemocare(r), LifeLine(tm) (Blood Bank), WORx(r), MediCOE(tm), MediMAR(tm), Pharmakon(r) and Digimedics(tm) (Medication Management), Surgiware(tm) and Perioperative Solutions(tm) (Operating Room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom.
Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2005, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.